1. Home
  2. BMEA vs SPIR Comparison

BMEA vs SPIR Comparison

Compare BMEA & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • SPIR
  • Stock Information
  • Founded
  • BMEA 2017
  • SPIR 2012
  • Country
  • BMEA United States
  • SPIR United States
  • Employees
  • BMEA N/A
  • SPIR N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • SPIR Telecommunications Equipment
  • Sector
  • BMEA Health Care
  • SPIR Consumer Discretionary
  • Exchange
  • BMEA Nasdaq
  • SPIR Nasdaq
  • Market Cap
  • BMEA 275.6M
  • SPIR 238.3M
  • IPO Year
  • BMEA 2021
  • SPIR N/A
  • Fundamental
  • Price
  • BMEA $11.24
  • SPIR $9.25
  • Analyst Decision
  • BMEA Buy
  • SPIR Buy
  • Analyst Count
  • BMEA 13
  • SPIR 6
  • Target Price
  • BMEA $36.33
  • SPIR $14.20
  • AVG Volume (30 Days)
  • BMEA 1.1M
  • SPIR 180.3K
  • Earning Date
  • BMEA 11-01-2024
  • SPIR 11-06-2024
  • Dividend Yield
  • BMEA N/A
  • SPIR N/A
  • EPS Growth
  • BMEA N/A
  • SPIR N/A
  • EPS
  • BMEA N/A
  • SPIR N/A
  • Revenue
  • BMEA N/A
  • SPIR $107,223,000.00
  • Revenue This Year
  • BMEA N/A
  • SPIR $18.74
  • Revenue Next Year
  • BMEA N/A
  • SPIR $23.69
  • P/E Ratio
  • BMEA N/A
  • SPIR N/A
  • Revenue Growth
  • BMEA N/A
  • SPIR 24.15
  • 52 Week Low
  • BMEA $3.61
  • SPIR $3.27
  • 52 Week High
  • BMEA $22.74
  • SPIR $19.40
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 64.18
  • SPIR 45.26
  • Support Level
  • BMEA $10.35
  • SPIR $8.80
  • Resistance Level
  • BMEA $12.30
  • SPIR $9.93
  • Average True Range (ATR)
  • BMEA 0.93
  • SPIR 0.43
  • MACD
  • BMEA -0.01
  • SPIR -0.04
  • Stochastic Oscillator
  • BMEA 47.26
  • SPIR 31.79

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

Share on Social Networks: